>
产品中心 >
monoclonal_antibody >
BioXcell/InVivoPlus anti-mouse PD-1 (CD279)/DISCOUNTED ACADEMIC OR NON PROFIT 50MG/BP0146-A050mg
About InVivoMAb anti-mouse CD209b (SIGN-R1)
The 22D1 monoclonal antibody reacts with mouse CD209b also known as SIGN-R1. CD209b is a 37 kDa type II transmembrane C-type lectin receptor. CD209b is expressed on the surface of splenic marginal zone and lymph node medullary macrophages and is commonly used as a marker for these cells. The CD209b protein is involved in the innate immune response, it binds to and initiates uptake of various microorganisms by recognizing high-mannose-containing glycoproteins on their envelopes. The 22D1 antibody has been reported to block CD209b in vivo.
InVivoMAb anti-mouse CD209b (SIGN-R1) Specifications
Isotype | Armenian Hamster IgG, κ |
Recommended Isotype Control(s) | InVivoMAbpolyclonal Armenian hamster IgG(BE0091) |
Recommended InVivoPure Dilution Buffer | InVivoPure pH 7.0 Dilution Buffer(IP0070) |
Immunogen | C-terminal peptide of mouse SIGN-R1 |
Reported Applications |
|
Endotoxin |
|
Purity |
|
Formulation |
|
Sterility | 0.2 μM filtered |
Production | Purified from tissue culture supernatant in an animal free facility |
Purification | Protein G |
Storage | The antibody solution should be stored at the stock concentration at 4°C. Do not freeze. |
RRID | AB_2687704 |
Molecular Weight | 150 kDa |